STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session Is Patria PAX stock breaking out Q4 2025 Profit Surprises TJX Companies Inc TJX A Defensive Dividend Growth Play for Volatile Market Environments